BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05335941-completion@plaintrial.com
DTSTAMP:20261111T014142Z
DTSTART;VALUE=DATE:20270930
SUMMARY:A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed P
 lus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previousl
 y Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma — e
 stimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05335941
URL:https://plaintrial.com/trial/NCT05335941
END:VEVENT
END:VCALENDAR